Response to “No Increased Risk of Breast or Gynecologic Malignancies in Women Exposed to Spironolactone for Dermatologic Conditions: A Retrospective Cohort Study”
Author Type(s)
Student
Document Type
Letter to the Editor
Publication Date
12-1-2024
DOI
10.1016/j.jaad.2024.05.105
Journal Title
Journal of the American Academy of Dermatology
Keywords
breast cancer, malignancy, risk assessment, spironolactone
Disciplines
Medicine and Health Sciences
Recommended Citation
Desai, D., Sikora, M., Nohria, A., Caplan, A., Lacouture, M., Shapiro, J., & Lo Sicco, K. (2024). Response to “No Increased Risk of Breast or Gynecologic Malignancies in Women Exposed to Spironolactone for Dermatologic Conditions: A Retrospective Cohort Study”. Journal of the American Academy of Dermatology, 91 (6), e171-e172. https://doi.org/10.1016/j.jaad.2024.05.105
COinS
